Loading...
XHKG
0932
Market cap11mUSD
Jul 10, Last price  
0.03HKD
1D
-3.57%
1Q
-12.90%
Jan 2017
-96.91%
IPO
-95.73%
Name

Shunten International (Holdings) Ltd

Chart & Performance

D1W1MN
XHKG:0932 chart
P/E
P/S
0.42
EPS
Div Yield, %
Shrs. gr., 5y
3.92%
Rev. gr., 5y
-2.14%
Revenues
200m
-2.32%
163,767,000169,684,000227,677,000189,958,000220,853,000264,451,000393,487,000303,854,000223,147,000155,639,000216,127,000235,586,000205,048,000200,282,000
Net income
-27m
L-26.69%
39,264,000-5,733,00031,521,00010,421,00012,746,000-139,217,000-4,344,000-139,690,000-127,377,000-43,888,00041,036,000571,000-36,243,000-26,571,000
CFO
0k
-100.00%
911,0004,355,0007,500,00015,004,0003,563,000-21,780,000-22,921,000-28,023,00031,175,00010,465,0004,838,00038,777,00024,018,0000
Dividend
Aug 06, 20150.025 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shunten International (Holdings) Limited operates as an investment firm, primarily focusing on the marketing, sales, and distribution of health and beauty products and dietary supplements. Its commercial activities extend across Hong Kong, Taiwan, and international markets, offering items under both its proprietary labels and private label brands. Beyond these core operations, the company diversified into property investment, the management of licenses and trademarks, e-commerce promotion, traditional Chinese medical consultations, and health food processing. Additionally, it engages in the sale and distribution of various healthcare items, trades nutritional supplements, and delivers general administrative support services. Founded in 2002, the company was originally known as RM Group Holdings Limited, changing to its current designation in February 2018. Its corporate headquarters are situated in Kwai Chung, Hong Kong.
IPO date
Oct 11, 2013
Employees
276
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT